Safety and Efficacy of Ibrutinib in a Patient With Severe Renal Impairment

Hematology Reports - Italy
doi 10.4081/hr.2017.7078
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

PAGEPress Publications

Related search

The Pharmacokinetics and Safety of Darapladib in Subjects With Severe Renal Impairment

British Journal of Clinical Pharmacology
Pharmacology
2015English

Safety of High-Dose Daptomycin in Patients With Severe Renal Impairment

Therapeutics and Clinical Risk Management
2018English

Severe Hypocalcemia Following a Single Injection of Denosumab in a Patient With Renal Impairment

Journal of Drug Assessment
2012English

Pharmacokinetics and Safety of Tenofovir Alafenamide in HIV-Uninfected Subjects With Severe Renal Impairment

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients With Renal Impairment

Pharmacy
2020English

Murepavadin, a Novel Antipseudomonal Antibiotic: Pharmacokinetics, Tolerability and Safety in Subjects With Mild, Moderate, and Severe Renal Function Impairment

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Severe Calciphylaxis in a Patient With End Stage Renal Disease

MOJ Clinical & Medical Case Reports
2015English

Case Report: Renal Impairment and Bilateral Cataracts in a Patient With Maffucci Syndrome

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2019English

Single-Dose Pharmacokinetics and Safety of Daclatasvir in Subjects With Renal Function Impairment

Antiviral Therapy
Infectious DiseasesPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy